Economic impact of diseases in the U.S. by medtech incentives 2010-2035

This statistic displays the projected economic impact in the United States by selected disease for the period from 2010 to 2035, by extent of medtech incentives. Under continued medtech incentives, heart disease would create an economic impact totaling about 7.7 trillion U.S. dollars during these years. The direct economic benefit of medical technology such as devices and diagnostics is simple to measure, however, including indirect costs such as reducing the length of hospital stays is more complex to find.

本统计数据显示了2010年至2035年期间，按选定疾病类别及医疗技术激励程度划分的美国预计经济影响。在持续的医疗技术激励政策下，心脏病将在这段时间内产生约7.7万亿美元的经济影响。医疗技术如设备和诊断的直接经济效益易于衡量，然而，包括减少住院时间等间接成本在内的综合考量则显得更为复杂。